QA: Aptinyx Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001674365_2020_Aptinyx_Inc.pdf

Logs

Graph

Absolute values for 0001674365, Aptinyx Inc.

  xvar xval
0 AssetsCurrent 105,109,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,204,000
3 remainder_Assets 166,000
4 LiabilitiesCurrent 4,896,000
5 LiabilitiesNoncurrent 272,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 18,952,000
9 ResearchAndDevelopmentExpense 44,330,000
10 remainder_Expenses 0
11 remainder_Revenues 3,669,000
12 remainder_NetIncome 2,203,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 106,479,000
1 Liabilities 5,168,000
2 Expenses 63,282,000
3 Revenues 3,669,000
4 StockholdersEquity 101,311,000
5 NetIncome -57,410,000
6 ComprehensiveNetIncome -57,410,000
7 BaseVar 90,400,500
8 EconomicCapitalRatio 2.09

Edgar->Model Mapping

Feature Distribution

Change over Time